Safety of potassium-binding agents in HFrEF: a meta-analysis of randomized trials
28 August 2026 (09:15 - 10:00)
Organised by: 
About the speaker
Centro Hospitalar E Universitario De Coimbra, Coimbra (Portugal)
6 More presentations in this session
Doctor R. Nakano-Kurimoto (Kyoto, JP)
Renin-angiotensin system inhibition and survival in elderly HFrEF with CKD: a target trial emulation
Doctor P. Puiu (Zurich, CH)
Professor L. Fauchier (Tours, FR)
Associate Professor T. Bekfani (Magdeburg, DE)
Assessment of venous congestion in HFrEF using VExUS in a cohort of patients treated with Vericiguat
Doctor F. Ferranti (Rome, IT)
Access the full session
The Event
ESC Congress 2026
28 August 2026
09:15 CET
You may be interested in
Congress Presentation
Congress Presentation
